Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for

Nazanin Zohourian1, Erin Coll1, Muiread Dever1

  • 1Department of Biological Science, University of Limerick, V94 T9PX Limerick, Ireland.

Cancers
|August 10, 2024
PubMed

Insights

Tip60, an epigenetic regulator, is often lost in cancer. Restoring its function offers a promising therapeutic strategy by targeting cancer

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Precision medicine uses molecular tumor profiling to guide targeted therapies.
  • Non-mutational epigenetic changes are hallmarks of cancer and are reversible.
  • Lysine acetyltransferases (KATs), like Tip60, regulate gene expression and genome stability.

Purpose of the Study:

  • To explore the roles of Tip60 in tumorigenesis.
  • To understand the impact of Tip60 mislocalization in cancer.
  • To evaluate Tip60-targeting compounds as epigenetic inhibitors for cancer therapy.

Main Methods:

  • Categorization of Tip60-regulated genes.
  • Evaluation of Tip60-interacting proteins based on cellular localization.
  • Exploration of therapeutic potential of Tip60-targeting compounds.

Main Results:

  • Tip60 is frequently downregulated and mislocalized in various cancers.
  • Tip60 plays critical roles in epigenetic regulation and DNA repair.
  • Understanding Tip60's functions can reveal new therapeutic strategies.

Conclusions:

  • Tip60's multifaceted roles in tumorigenesis require further investigation.
  • Targeting Tip60 may offer novel epigenetic therapeutic options.
  • Combinatorial therapies involving Tip60 modulators could improve patient outcomes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K